UK Companies House feature
BRIGHTWAKE LIMITED
Cash
£823K
-29.2% vs 2024
Net assets
£8M
-12.1% vs 2024
Employees
230
-0.4% vs 2024
Profit before tax
—
Period ending 2025-03-31
Profile
- Company number
- 01356034
- Status
- Active
- Incorporation
- 1978-03-07
- Last accounts made up
- 2025-03-31
- Account category
- GROUP
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Net assets
7-year trend · vs UK Healthcare median
BRIGHTWAKE LIMITED
BRIGHTWAKE LIMITED
BRIGHTWAKE LIMITED
BRIGHTWAKE LIMITED
Accounts
7-year trend · latest 2025-03-31
| Metric | Trend | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | — | — | |
| Net profit | — | — | — | — | — | — | — | |
| Cash | — | — | — | — | — | £1,162,083 | £822,929 | |
| Total assets less current liabilities | — | — | — | — | — | £9,020,196 | £8,147,860 | |
| Net assets | — | — | — | — | — | £8,946,332 | £7,867,255 | |
| Equity | £7,471,473 | £7,514,155 | £8,088,899 | £8,135,175 | £8,569,524 | £8,946,332 | £7,867,255 | |
| Average employees | — | — | — | — | — | 231 | 230 | |
| Wages | — | — | — | — | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated (group)
- Auditor
- Sumer Auditco Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Subsidiaries
- Advancis Medical Germany Gmbh · 100% held · Germany · Sale of medical products
- Advancis Medical Nederland B.V. · 100% held · Holland · Sale of medical products
- Brightwake Fabrications Limited · 100% held · UK · Design and manufacture of precision engineering
- Advancis Medical Adria d.o.o · 100% held · Croatia · Sale of medical products
Significant events
- “A difficult year that due to several factors has limited progress in both our medium and long-term plans, to be one of the best inventors, developers and producers of state-of-the-art medical dressings and devices primarily, under our brands of Advancis Medical, Advancis Surgical and Advancis Veterinary as well as for third parties as a sub-contract manufacturer.”
- “The year was impacted by continued global and political uncertainty exacerbated by speculation that curtailed all our long-term investment plans.”
- “Turnover in the year fell from £20.4m to £18.9m a reduction of £1.5m (7.5%) the significant reductions were the loss in OEM Sales (£1.9m) due to the significantly reduced demand from a single customer for a single product where their sales were significantly less than expected.”
- “Our German Subsidiary also saw sales diminish by £0.4m due to the reimbursement status of our honey products being left in limbo after the collapse in the Bundestag in the final quarter of 2024. Reimbursement status was restored after the year end.”
- “The year highlighted our dependency on single product OEM contracts along with the risk of rapid change in National Product Registrations.”
- “Our year was further impacted by patent litigation which combined with supporting new businesses and the diminished sales took the group to a substantial loss for the year. The litigation was brought against us at a group and subsidiary level on a single product and whilst we had grounds to fight based on us having pre-dated patents, the fact it was only one product with key sales only in Germany and the US lead to us settling the dispute. The total cost to the group of the settlement, fees and removing the product from sale was circa £600k.”
- “In the year we had losses from Croatia of (£0.1m) due to the continued irregular practices within the territory as we have transitioned to a subsidiary entity.”
- “Support of the fabrications business cost the group (£0.4m) exacerbated by a significant bad debt of (£0.10m)”
- “Germany following the lost sales in the last three months of the year lost (£0.2m)”
- “The UK losses as a result of the lost OEM business and the legal costs of litigation lost (£1.3m).”
- “The result for the year shows EBITDA at (£1.349m) from £798k in 2024”
- “The Board has always insisted on retaining cash reserves to weather bad times, 2024/25 was a bad time and saw Group cash drop to £1m in March 25, however by December 25 this had recovered to in excess of £2.2m.”
- “The ongoing change in the UK and EU regulatory framework continues to be of concern going forward especially with the lack of Registered Body Capacity slowing product development.”
- “Growth in our Surgical Brand continues to be stifled by past delays in elective surgeries.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ALLEN, Victoria Claire | Secretary | 2001-03-06 | — | British |
| ALLEN, Kenneth Alfred | Director | — | Aug 1948 | English |
| COTTON, Stephen | Director | 2013-04-18 | Nov 1966 | English |
| ENGLAND, Valerie | Director | 2009-01-09 | Aug 1958 | British |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALLEN, Valerie Mary | Secretary | — | 2001-02-20 |
| ALLEN, Valerie Mary | Director | — | 2001-02-20 |
| CLARK, Charlotte Louise | Director | 2001-03-06 | 2009-01-09 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Kenneth Alfred Allen | Individual | Shares 50–75%, Voting 50–75%, Appoints directors | 2016-07-12 | Active |
Filing timeline
Last 20 of 107 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-27 | AA | accounts | accounts with accounts type group |
| 2025-08-13 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-12-23 | AA | accounts | accounts with accounts type group |
| 2024-09-24 | PSC04 | persons-with-significant-control | change to a person with significant control |
| 2024-08-15 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-12-27 | AA | accounts | accounts with accounts type group |
| 2023-08-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-03-30 | AA | accounts | accounts with accounts type group |
| 2022-09-12 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-01-31 | AA | accounts | accounts with accounts type group |
| 2021-08-19 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-06-30 | AA | accounts | accounts with accounts type group |
| 2020-07-30 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2019-12-20 | AA | accounts | accounts with accounts type group |
| 2019-09-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2019-03-27 | AA | accounts | accounts with accounts type group |
| 2018-07-23 | CS01 | confirmation-statement | confirmation statement with updates |
| 2018-01-30 | AA | accounts | accounts with accounts type group |
| 2017-09-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2017-03-29 | AA | accounts | accounts with accounts type group |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires EBIT (operating profit / PBT) — not present in the latest extracted accounts.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.